nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—prostate cancer	0.376	1	CbGaD
Lisinopril—ABCB1—Estramustine—prostate cancer	0.0536	0.2	CbGbCtD
Lisinopril—ABCB1—Cabazitaxel—prostate cancer	0.0353	0.132	CbGbCtD
Lisinopril—ABCB1—Estrone—prostate cancer	0.0345	0.129	CbGbCtD
Lisinopril—ABCB1—Ethinyl Estradiol—prostate cancer	0.0308	0.115	CbGbCtD
Lisinopril—ABCB1—Conjugated Estrogens—prostate cancer	0.0226	0.0843	CbGbCtD
Lisinopril—ABCB1—Mitoxantrone—prostate cancer	0.0205	0.0767	CbGbCtD
Lisinopril—ABCB1—Estradiol—prostate cancer	0.0198	0.074	CbGbCtD
Lisinopril—ABCB1—Prednisone—prostate cancer	0.017	0.0637	CbGbCtD
Lisinopril—ABCB1—Etoposide—prostate cancer	0.0129	0.0483	CbGbCtD
Lisinopril—ABCB1—Docetaxel—prostate cancer	0.0118	0.0442	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—prostate cancer	0.00883	0.033	CbGbCtD
Lisinopril—ACE2—prostate gland—prostate cancer	0.00646	0.159	CbGeAlD
Lisinopril—ACE—urine—prostate cancer	0.00588	0.145	CbGeAlD
Lisinopril—ACE2—renal system—prostate cancer	0.0044	0.108	CbGeAlD
Lisinopril—ACE2—testis—prostate cancer	0.00285	0.0699	CbGeAlD
Lisinopril—SLC15A1—epithelium—prostate cancer	0.00217	0.0532	CbGeAlD
Lisinopril—ACE—prostate gland—prostate cancer	0.00211	0.0519	CbGeAlD
Lisinopril—ACE2—lymph node—prostate cancer	0.00206	0.0507	CbGeAlD
Lisinopril—SLC15A1—renal system—prostate cancer	0.00201	0.0493	CbGeAlD
Lisinopril—ACE—seminal vesicle—prostate cancer	0.00179	0.0439	CbGeAlD
Lisinopril—ACE—epithelium—prostate cancer	0.00155	0.0381	CbGeAlD
Lisinopril—ACE—renal system—prostate cancer	0.00144	0.0354	CbGeAlD
Lisinopril—ACE—urethra—prostate cancer	0.00141	0.0347	CbGeAlD
Lisinopril—ACE—bone marrow—prostate cancer	0.00109	0.0267	CbGeAlD
Lisinopril—ACE—testis—prostate cancer	0.000931	0.0229	CbGeAlD
Lisinopril—ABCB1—prostate gland—prostate cancer	0.000744	0.0183	CbGeAlD
Lisinopril—ACE—lymph node—prostate cancer	0.000675	0.0166	CbGeAlD
Lisinopril—ABCB1—seminal vesicle—prostate cancer	0.000629	0.0155	CbGeAlD
Lisinopril—ABCB1—epithelium—prostate cancer	0.000546	0.0134	CbGeAlD
Lisinopril—Fosinopril—ACE—prostate cancer	0.000516	0.123	CrCbGaD
Lisinopril—ABCB1—renal system—prostate cancer	0.000507	0.0125	CbGeAlD
Lisinopril—ABCB1—urethra—prostate cancer	0.000498	0.0122	CbGeAlD
Lisinopril—Spirapril—ACE—prostate cancer	0.000416	0.0991	CrCbGaD
Lisinopril—Moexipril—ACE—prostate cancer	0.000398	0.095	CrCbGaD
Lisinopril—Benazepril—MTHFR—prostate cancer	0.000395	0.0943	CrCbGaD
Lisinopril—ABCB1—bone marrow—prostate cancer	0.000383	0.00942	CbGeAlD
Lisinopril—Cilazapril—ACE—prostate cancer	0.00037	0.0883	CrCbGaD
Lisinopril—Quinapril—ACE—prostate cancer	0.00037	0.0883	CrCbGaD
Lisinopril—Ramipril—ACE—prostate cancer	0.000359	0.0855	CrCbGaD
Lisinopril—Trandolapril—ACE—prostate cancer	0.000359	0.0855	CrCbGaD
Lisinopril—ABCB1—testis—prostate cancer	0.000328	0.00805	CbGeAlD
Lisinopril—Benazepril—ACE—prostate cancer	0.000322	0.0768	CrCbGaD
Lisinopril—Enalapril—ACE—prostate cancer	0.000272	0.0648	CrCbGaD
Lisinopril—ABCB1—lymph node—prostate cancer	0.000237	0.00583	CbGeAlD
Lisinopril—Nateglinide—CYP3A5—prostate cancer	0.000201	0.048	CrCbGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.000151	0.0021	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—CTNNB1—prostate cancer	0.00015	0.00207	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—PLAUR—prostate cancer	0.000149	0.00207	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000144	0.002	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL12—prostate cancer	0.000141	0.00195	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VIM—prostate cancer	0.000138	0.00191	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—HSP90B1—prostate cancer	0.000133	0.00185	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.00013	0.0018	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF3A—prostate cancer	0.000129	0.00179	CbGpPWpGaD
Lisinopril—Enalapril—CYP3A4—prostate cancer	0.000128	0.0304	CrCbGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000126	0.00174	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.000124	0.00172	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—prostate cancer	0.000124	0.00172	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MME—prostate cancer	0.000115	0.00159	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GRP—prostate cancer	0.00011	0.00152	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	0.000107	0.00149	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL10—prostate cancer	0.000107	0.00148	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	0.000105	0.00145	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—prostate cancer	0.000103	0.00143	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000103	0.00142	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NCOA2—prostate cancer	0.000101	0.0014	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	9.99e-05	0.00139	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	9.99e-05	0.00139	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ATF3—prostate cancer	9.57e-05	0.00133	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	9.49e-05	0.00132	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—prostate cancer	9.38e-05	0.0013	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGFBP3—prostate cancer	9.01e-05	0.00125	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—INS—prostate cancer	8.81e-05	0.00122	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ACHE—prostate cancer	8.79e-05	0.00122	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—prostate cancer	8.78e-05	0.00122	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—PRKCZ—prostate cancer	8.72e-05	0.00121	CbGpPWpGaD
Lisinopril—Nateglinide—CYP3A4—prostate cancer	8.72e-05	0.0208	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—prostate cancer	8.52e-05	0.00118	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	8.51e-05	0.00118	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NCOA1—prostate cancer	8.48e-05	0.00118	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPS19—prostate cancer	8.45e-05	0.00117	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CTSD—prostate cancer	8.32e-05	0.00115	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP2—prostate cancer	8.25e-05	0.00114	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—THBS1—prostate cancer	8.2e-05	0.00114	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL12—prostate cancer	8.12e-05	0.00113	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	8.11e-05	0.00112	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CALR—prostate cancer	7.79e-05	0.00108	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP9—prostate cancer	7.65e-05	0.00106	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	7.63e-05	0.00106	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.48e-05	0.00104	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—prostate cancer	6.85e-05	0.00095	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLAUR—prostate cancer	6.66e-05	0.000924	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.61e-05	0.000916	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CTNNB1—prostate cancer	6.32e-05	0.000877	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	6.29e-05	0.000872	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TERT—prostate cancer	6.27e-05	0.000869	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL10—prostate cancer	6.16e-05	0.000854	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	6.02e-05	0.000835	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—prostate cancer	5.99e-05	0.000831	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—prostate cancer	5.85e-05	0.000811	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	5.78e-05	0.000802	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FASLG—prostate cancer	5.72e-05	0.000794	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	5.48e-05	0.00076	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	5.38e-05	0.000746	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.36e-05	0.000743	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.05e-05	0.000701	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	4.92e-05	0.000682	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	4.89e-05	0.000679	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	4.89e-05	0.000678	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.82e-05	0.000669	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	4.82e-05	0.000668	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	4.77e-05	0.000662	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	4.66e-05	0.000647	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—prostate cancer	4.61e-05	0.000639	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	4.59e-05	0.000637	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	4.47e-05	0.00062	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	4.45e-05	0.000617	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	4.38e-05	0.000608	CbGpPWpGaD
Lisinopril—Agranulocytosis—Doxorubicin—prostate cancer	4.26e-05	0.000178	CcSEcCtD
Lisinopril—Rash—Mitoxantrone—prostate cancer	4.26e-05	0.000178	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.26e-05	0.000591	CbGpPWpGaD
Lisinopril—Dermatitis—Mitoxantrone—prostate cancer	4.26e-05	0.000178	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.26e-05	0.000178	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	4.25e-05	0.00059	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	4.25e-05	0.000589	CbGpPWpGaD
Lisinopril—Headache—Mitoxantrone—prostate cancer	4.23e-05	0.000177	CcSEcCtD
Lisinopril—Hypotension—Capecitabine—prostate cancer	4.23e-05	0.000177	CcSEcCtD
Lisinopril—Insomnia—Docetaxel—prostate cancer	4.22e-05	0.000177	CcSEcCtD
Lisinopril—Arthralgia—Prednisone—prostate cancer	4.2e-05	0.000176	CcSEcCtD
Lisinopril—Myalgia—Prednisone—prostate cancer	4.2e-05	0.000176	CcSEcCtD
Lisinopril—Paraesthesia—Docetaxel—prostate cancer	4.19e-05	0.000175	CcSEcCtD
Lisinopril—Erythema multiforme—Epirubicin—prostate cancer	4.19e-05	0.000175	CcSEcCtD
Lisinopril—Anxiety—Prednisone—prostate cancer	4.19e-05	0.000175	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—prostate cancer	4.18e-05	0.000175	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	4.17e-05	0.000579	CbGpPWpGaD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.17e-05	0.000174	CcSEcCtD
Lisinopril—Dyspnoea—Docetaxel—prostate cancer	4.16e-05	0.000174	CcSEcCtD
Lisinopril—Somnolence—Docetaxel—prostate cancer	4.15e-05	0.000174	CcSEcCtD
Lisinopril—Discomfort—Prednisone—prostate cancer	4.15e-05	0.000174	CcSEcCtD
Lisinopril—Hypersensitivity—Etoposide—prostate cancer	4.14e-05	0.000173	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—prostate cancer	4.13e-05	0.000173	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.12e-05	0.000172	CcSEcCtD
Lisinopril—Flushing—Epirubicin—prostate cancer	4.12e-05	0.000172	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—prostate cancer	4.11e-05	0.000172	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—prostate cancer	4.11e-05	0.000172	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—prostate cancer	4.1e-05	0.000172	CcSEcCtD
Lisinopril—Insomnia—Capecitabine—prostate cancer	4.09e-05	0.000171	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—prostate cancer	4.07e-05	0.00017	CcSEcCtD
Lisinopril—Paraesthesia—Capecitabine—prostate cancer	4.06e-05	0.00017	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—prostate cancer	4.06e-05	0.00017	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—prostate cancer	4.05e-05	0.000169	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.05e-05	0.000562	CbGpPWpGaD
Lisinopril—Oedema peripheral—Doxorubicin—prostate cancer	4.04e-05	0.000169	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—prostate cancer	4.03e-05	0.000169	CcSEcCtD
Lisinopril—Asthenia—Etoposide—prostate cancer	4.03e-05	0.000169	CcSEcCtD
Lisinopril—Dyspnoea—Capecitabine—prostate cancer	4.03e-05	0.000169	CcSEcCtD
Lisinopril—Anaphylactic shock—Prednisone—prostate cancer	4.03e-05	0.000168	CcSEcCtD
Lisinopril—Oedema—Prednisone—prostate cancer	4.03e-05	0.000168	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—prostate cancer	4.03e-05	0.000168	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—prostate cancer	4.02e-05	0.000168	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—prostate cancer	4.02e-05	0.000168	CcSEcCtD
Lisinopril—Nausea—Mitoxantrone—prostate cancer	4.01e-05	0.000168	CcSEcCtD
Lisinopril—Infection—Prednisone—prostate cancer	4e-05	0.000167	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—prostate cancer	4e-05	0.000167	CcSEcCtD
Lisinopril—Constipation—Docetaxel—prostate cancer	3.99e-05	0.000167	CcSEcCtD
Lisinopril—Pain—Docetaxel—prostate cancer	3.99e-05	0.000167	CcSEcCtD
Lisinopril—Dyspepsia—Capecitabine—prostate cancer	3.98e-05	0.000166	CcSEcCtD
Lisinopril—Chills—Epirubicin—prostate cancer	3.98e-05	0.000166	CcSEcCtD
Lisinopril—Pruritus—Etoposide—prostate cancer	3.98e-05	0.000166	CcSEcCtD
Lisinopril—Shock—Prednisone—prostate cancer	3.96e-05	0.000166	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—prostate cancer	3.96e-05	0.000166	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	3.94e-05	0.000546	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—INS—prostate cancer	3.94e-05	0.000546	CbGpPWpGaD
Lisinopril—Tachycardia—Prednisone—prostate cancer	3.93e-05	0.000164	CcSEcCtD
Lisinopril—Decreased appetite—Capecitabine—prostate cancer	3.93e-05	0.000164	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—prostate cancer	3.92e-05	0.000164	CcSEcCtD
Lisinopril—Skin disorder—Prednisone—prostate cancer	3.91e-05	0.000164	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Capecitabine—prostate cancer	3.9e-05	0.000163	CcSEcCtD
Lisinopril—Fatigue—Capecitabine—prostate cancer	3.9e-05	0.000163	CcSEcCtD
Lisinopril—Hyperhidrosis—Prednisone—prostate cancer	3.89e-05	0.000163	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—prostate cancer	3.88e-05	0.000162	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—prostate cancer	3.88e-05	0.000162	CcSEcCtD
Lisinopril—Pain—Capecitabine—prostate cancer	3.87e-05	0.000162	CcSEcCtD
Lisinopril—Constipation—Capecitabine—prostate cancer	3.87e-05	0.000162	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—prostate cancer	3.86e-05	0.000161	CcSEcCtD
Lisinopril—Erythema—Epirubicin—prostate cancer	3.86e-05	0.000161	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—prostate cancer	3.85e-05	0.000161	CcSEcCtD
Lisinopril—Diarrhoea—Etoposide—prostate cancer	3.85e-05	0.000161	CcSEcCtD
Lisinopril—Anorexia—Prednisone—prostate cancer	3.84e-05	0.000161	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—prostate cancer	3.83e-05	0.00016	CcSEcCtD
Lisinopril—Gastrointestinal pain—Docetaxel—prostate cancer	3.82e-05	0.00016	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	3.81e-05	0.000529	CbGpPWpGaD
Lisinopril—Flushing—Doxorubicin—prostate cancer	3.81e-05	0.000159	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGF1—prostate cancer	3.81e-05	0.000528	CbGpPWpGaD
Lisinopril—Flatulence—Epirubicin—prostate cancer	3.8e-05	0.000159	CcSEcCtD
Lisinopril—Tension—Epirubicin—prostate cancer	3.79e-05	0.000158	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—prostate cancer	3.78e-05	0.000158	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	3.78e-05	0.000524	CbGpPWpGaD
Lisinopril—Nervousness—Epirubicin—prostate cancer	3.75e-05	0.000157	CcSEcCtD
Lisinopril—Back pain—Epirubicin—prostate cancer	3.73e-05	0.000156	CcSEcCtD
Lisinopril—Feeling abnormal—Capecitabine—prostate cancer	3.73e-05	0.000156	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—prostate cancer	3.72e-05	0.000156	CcSEcCtD
Lisinopril—Dizziness—Etoposide—prostate cancer	3.72e-05	0.000155	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—prostate cancer	3.71e-05	0.000155	CcSEcCtD
Lisinopril—Gastrointestinal pain—Capecitabine—prostate cancer	3.7e-05	0.000155	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—prostate cancer	3.7e-05	0.000155	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—prostate cancer	3.69e-05	0.000154	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—prostate cancer	3.69e-05	0.000154	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	3.69e-05	0.000511	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—prostate cancer	3.68e-05	0.000511	CbGpPWpGaD
Lisinopril—Chills—Doxorubicin—prostate cancer	3.68e-05	0.000154	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	3.68e-05	0.00051	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Prednisone—prostate cancer	3.67e-05	0.000153	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—prostate cancer	3.67e-05	0.000153	CcSEcCtD
Lisinopril—Insomnia—Prednisone—prostate cancer	3.64e-05	0.000152	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—prostate cancer	3.64e-05	0.000152	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—prostate cancer	3.63e-05	0.000152	CcSEcCtD
Lisinopril—Paraesthesia—Prednisone—prostate cancer	3.62e-05	0.000151	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—prostate cancer	3.59e-05	0.00015	CcSEcCtD
Lisinopril—Urticaria—Capecitabine—prostate cancer	3.59e-05	0.00015	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—prostate cancer	3.58e-05	0.00015	CcSEcCtD
Lisinopril—Abdominal pain—Capecitabine—prostate cancer	3.57e-05	0.000149	CcSEcCtD
Lisinopril—Body temperature increased—Capecitabine—prostate cancer	3.57e-05	0.000149	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	3.57e-05	0.000496	CbGpPWpGaD
Lisinopril—Vomiting—Etoposide—prostate cancer	3.57e-05	0.000149	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—prostate cancer	3.57e-05	0.000149	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—prostate cancer	3.57e-05	0.000149	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—prostate cancer	3.57e-05	0.000149	CcSEcCtD
Lisinopril—Dyspepsia—Prednisone—prostate cancer	3.55e-05	0.000148	CcSEcCtD
Lisinopril—Rash—Etoposide—prostate cancer	3.54e-05	0.000148	CcSEcCtD
Lisinopril—Dermatitis—Etoposide—prostate cancer	3.54e-05	0.000148	CcSEcCtD
Lisinopril—Headache—Etoposide—prostate cancer	3.52e-05	0.000147	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—prostate cancer	3.52e-05	0.000147	CcSEcCtD
Lisinopril—Tension—Doxorubicin—prostate cancer	3.5e-05	0.000147	CcSEcCtD
Lisinopril—Decreased appetite—Prednisone—prostate cancer	3.5e-05	0.000146	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—prostate cancer	3.5e-05	0.000146	CcSEcCtD
Lisinopril—Malaise—Epirubicin—prostate cancer	3.48e-05	0.000146	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	3.48e-05	0.000482	CbGpPWpGaD
Lisinopril—Fatigue—Prednisone—prostate cancer	3.47e-05	0.000145	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—prostate cancer	3.47e-05	0.000145	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—prostate cancer	3.47e-05	0.000145	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	3.47e-05	0.000481	CbGpPWpGaD
Lisinopril—Syncope—Epirubicin—prostate cancer	3.46e-05	0.000145	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—prostate cancer	3.46e-05	0.000144	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—prostate cancer	3.45e-05	0.000144	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	3.45e-05	0.000478	CbGpPWpGaD
Lisinopril—Constipation—Prednisone—prostate cancer	3.44e-05	0.000144	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—prostate cancer	3.44e-05	0.000144	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—prostate cancer	3.43e-05	0.000144	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—prostate cancer	3.41e-05	0.000143	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—prostate cancer	3.39e-05	0.000142	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	3.38e-05	0.000469	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	3.38e-05	0.000469	CbGpPWpGaD
Lisinopril—Cough—Epirubicin—prostate cancer	3.37e-05	0.000141	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—prostate cancer	3.37e-05	0.000467	CbGpPWpGaD
Lisinopril—Vision blurred—Doxorubicin—prostate cancer	3.37e-05	0.000141	CcSEcCtD
Lisinopril—Asthenia—Docetaxel—prostate cancer	3.35e-05	0.00014	CcSEcCtD
Lisinopril—Nausea—Etoposide—prostate cancer	3.34e-05	0.00014	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	3.33e-05	0.000462	CbGpPWpGaD
Lisinopril—Hypersensitivity—Capecitabine—prostate cancer	3.33e-05	0.000139	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisone—prostate cancer	3.32e-05	0.000139	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—prostate cancer	3.31e-05	0.000139	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—prostate cancer	3.3e-05	0.000138	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—prostate cancer	3.3e-05	0.000138	CcSEcCtD
Lisinopril—Gastrointestinal pain—Prednisone—prostate cancer	3.29e-05	0.000138	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—prostate cancer	3.29e-05	0.000137	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—prostate cancer	3.29e-05	0.000137	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—prostate cancer	3.29e-05	0.000137	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—prostate cancer	3.27e-05	0.000137	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.26e-05	0.000136	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—prostate cancer	3.25e-05	0.000136	CcSEcCtD
Lisinopril—Asthenia—Capecitabine—prostate cancer	3.24e-05	0.000136	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	3.23e-05	0.000448	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP3—prostate cancer	3.22e-05	0.000447	CbGpPWpGaD
Lisinopril—Malaise—Doxorubicin—prostate cancer	3.22e-05	0.000135	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL2—prostate cancer	3.22e-05	0.000446	CbGpPWpGaD
Lisinopril—Dry mouth—Epirubicin—prostate cancer	3.21e-05	0.000134	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—prostate cancer	3.21e-05	0.000134	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—prostate cancer	3.2e-05	0.000134	CcSEcCtD
Lisinopril—Urticaria—Prednisone—prostate cancer	3.2e-05	0.000134	CcSEcCtD
Lisinopril—Pruritus—Capecitabine—prostate cancer	3.2e-05	0.000134	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—prostate cancer	3.2e-05	0.000134	CcSEcCtD
Lisinopril—Diarrhoea—Docetaxel—prostate cancer	3.2e-05	0.000134	CcSEcCtD
Lisinopril—Abdominal pain—Prednisone—prostate cancer	3.18e-05	0.000133	CcSEcCtD
Lisinopril—Body temperature increased—Prednisone—prostate cancer	3.18e-05	0.000133	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—prostate cancer	3.18e-05	0.000133	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	3.17e-05	0.00044	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	3.16e-05	0.000438	CbGpPWpGaD
Lisinopril—Palpitations—Doxorubicin—prostate cancer	3.16e-05	0.000132	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—prostate cancer	3.15e-05	0.000132	CcSEcCtD
Lisinopril—Oedema—Epirubicin—prostate cancer	3.15e-05	0.000132	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—prostate cancer	3.14e-05	0.000131	CcSEcCtD
Lisinopril—Infection—Epirubicin—prostate cancer	3.13e-05	0.000131	CcSEcCtD
Lisinopril—Cough—Doxorubicin—prostate cancer	3.12e-05	0.00013	CcSEcCtD
Lisinopril—Shock—Epirubicin—prostate cancer	3.1e-05	0.00013	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.09e-05	0.000429	CbGpPWpGaD
Lisinopril—Diarrhoea—Capecitabine—prostate cancer	3.09e-05	0.000129	CcSEcCtD
Lisinopril—ABCB1—Metabolism—HAO1—prostate cancer	3.09e-05	0.000429	CbGpPWpGaD
Lisinopril—Dizziness—Docetaxel—prostate cancer	3.09e-05	0.000129	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—prostate cancer	3.08e-05	0.000129	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—prostate cancer	3.07e-05	0.000129	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	3.07e-05	0.000426	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—prostate cancer	3.06e-05	0.000425	CbGpPWpGaD
Lisinopril—Skin disorder—Epirubicin—prostate cancer	3.06e-05	0.000128	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—prostate cancer	3.05e-05	0.000127	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—prostate cancer	3.04e-05	0.000127	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—prostate cancer	3.04e-05	0.000127	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—prostate cancer	3.04e-05	0.000127	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—prostate cancer	3.03e-05	0.000127	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.02e-05	0.000126	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—prostate cancer	3e-05	0.000126	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—prostate cancer	3e-05	0.000126	CcSEcCtD
Lisinopril—Dizziness—Capecitabine—prostate cancer	2.99e-05	0.000125	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—prostate cancer	2.97e-05	0.000124	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—prostate cancer	2.97e-05	0.000124	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisone—prostate cancer	2.97e-05	0.000124	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.96e-05	0.000411	CbGpPWpGaD
Lisinopril—Rash—Docetaxel—prostate cancer	2.94e-05	0.000123	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—prostate cancer	2.94e-05	0.000123	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—prostate cancer	2.94e-05	0.000123	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—prostate cancer	2.94e-05	0.000123	CcSEcCtD
Lisinopril—Headache—Docetaxel—prostate cancer	2.93e-05	0.000122	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—prostate cancer	2.91e-05	0.000122	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—prostate cancer	2.91e-05	0.000122	CcSEcCtD
Lisinopril—Infection—Doxorubicin—prostate cancer	2.9e-05	0.000121	CcSEcCtD
Lisinopril—Asthenia—Prednisone—prostate cancer	2.89e-05	0.000121	CcSEcCtD
Lisinopril—Vomiting—Capecitabine—prostate cancer	2.88e-05	0.00012	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.87e-05	0.00012	CcSEcCtD
Lisinopril—Shock—Doxorubicin—prostate cancer	2.87e-05	0.00012	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—prostate cancer	2.85e-05	0.000119	CcSEcCtD
Lisinopril—Rash—Capecitabine—prostate cancer	2.85e-05	0.000119	CcSEcCtD
Lisinopril—Pruritus—Prednisone—prostate cancer	2.85e-05	0.000119	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—prostate cancer	2.85e-05	0.000119	CcSEcCtD
Lisinopril—Dermatitis—Capecitabine—prostate cancer	2.85e-05	0.000119	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—prostate cancer	2.84e-05	0.000119	CcSEcCtD
Lisinopril—Headache—Capecitabine—prostate cancer	2.83e-05	0.000118	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—prostate cancer	2.83e-05	0.000118	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—prostate cancer	2.83e-05	0.000118	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	2.82e-05	0.000392	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CTNNB1—prostate cancer	2.82e-05	0.000392	CbGpPWpGaD
Lisinopril—Hyperhidrosis—Doxorubicin—prostate cancer	2.82e-05	0.000118	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—prostate cancer	2.81e-05	0.000117	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—prostate cancer	2.8e-05	0.000117	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—prostate cancer	2.78e-05	0.000116	CcSEcCtD
Lisinopril—Nausea—Docetaxel—prostate cancer	2.77e-05	0.000116	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—prostate cancer	2.77e-05	0.000116	CcSEcCtD
Lisinopril—Diarrhoea—Prednisone—prostate cancer	2.76e-05	0.000115	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.74e-05	0.00038	CbGpPWpGaD
Lisinopril—Decreased appetite—Epirubicin—prostate cancer	2.74e-05	0.000115	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—prostate cancer	2.73e-05	0.000379	CbGpPWpGaD
Lisinopril—Hypotension—Doxorubicin—prostate cancer	2.72e-05	0.000114	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—prostate cancer	2.72e-05	0.000114	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—prostate cancer	2.72e-05	0.000114	CcSEcCtD
Lisinopril—Pain—Epirubicin—prostate cancer	2.69e-05	0.000113	CcSEcCtD
Lisinopril—Constipation—Epirubicin—prostate cancer	2.69e-05	0.000113	CcSEcCtD
Lisinopril—Nausea—Capecitabine—prostate cancer	2.69e-05	0.000112	CcSEcCtD
Lisinopril—Dizziness—Prednisone—prostate cancer	2.66e-05	0.000111	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.66e-05	0.000111	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—prostate cancer	2.64e-05	0.00011	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—prostate cancer	2.62e-05	0.000109	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—prostate cancer	2.6e-05	0.000109	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—prostate cancer	2.6e-05	0.000109	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—prostate cancer	2.59e-05	0.000108	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—prostate cancer	2.58e-05	0.000108	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—prostate cancer	2.57e-05	0.000107	CcSEcCtD
Lisinopril—Vomiting—Prednisone—prostate cancer	2.56e-05	0.000107	CcSEcCtD
Lisinopril—Rash—Prednisone—prostate cancer	2.54e-05	0.000106	CcSEcCtD
Lisinopril—Dermatitis—Prednisone—prostate cancer	2.54e-05	0.000106	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—prostate cancer	2.53e-05	0.000106	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.53e-05	0.000351	CbGpPWpGaD
Lisinopril—Headache—Prednisone—prostate cancer	2.52e-05	0.000106	CcSEcCtD
Lisinopril—ABCB1—Metabolism—TST—prostate cancer	2.52e-05	0.000349	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PSAT1—prostate cancer	2.52e-05	0.000349	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CBR1—prostate cancer	2.52e-05	0.000349	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GRHL1—prostate cancer	2.52e-05	0.000349	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADI1—prostate cancer	2.52e-05	0.000349	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CSAD—prostate cancer	2.52e-05	0.000349	CbGpPWpGaD
Lisinopril—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.52e-05	0.000105	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—prostate cancer	2.51e-05	0.000105	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—prostate cancer	2.51e-05	0.000348	CbGpPWpGaD
Lisinopril—Urticaria—Epirubicin—prostate cancer	2.5e-05	0.000105	CcSEcCtD
Lisinopril—Pain—Doxorubicin—prostate cancer	2.49e-05	0.000104	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—prostate cancer	2.49e-05	0.000104	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—prostate cancer	2.49e-05	0.000104	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—prostate cancer	2.49e-05	0.000104	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.46e-05	0.000341	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	2.41e-05	0.000334	CbGpPWpGaD
Lisinopril—Feeling abnormal—Doxorubicin—prostate cancer	2.4e-05	0.0001	CcSEcCtD
Lisinopril—Nausea—Prednisone—prostate cancer	2.39e-05	0.0001	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	2.39e-05	0.000331	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Doxorubicin—prostate cancer	2.38e-05	9.97e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—GRHPR—prostate cancer	2.34e-05	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UGT2B17—prostate cancer	2.34e-05	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UGT2B15—prostate cancer	2.34e-05	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CKMT2—prostate cancer	2.34e-05	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	2.33e-05	0.000323	CbGpPWpGaD
Lisinopril—Hypersensitivity—Epirubicin—prostate cancer	2.32e-05	9.71e-05	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—prostate cancer	2.32e-05	9.68e-05	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—prostate cancer	2.3e-05	9.64e-05	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—prostate cancer	2.3e-05	9.64e-05	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—prostate cancer	2.26e-05	9.45e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	2.26e-05	0.000313	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	2.23e-05	0.00031	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	2.23e-05	0.000309	CbGpPWpGaD
Lisinopril—Pruritus—Epirubicin—prostate cancer	2.23e-05	9.32e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—SULT2B1—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAGLU—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MBTPS1—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PGAM2—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM3—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AOX1—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RFK—prostate cancer	2.2e-05	0.000305	CbGpPWpGaD
Lisinopril—Diarrhoea—Epirubicin—prostate cancer	2.16e-05	9.01e-05	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—prostate cancer	2.15e-05	8.98e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	2.13e-05	0.000295	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	2.09e-05	0.00029	CbGpPWpGaD
Lisinopril—Asthenia—Doxorubicin—prostate cancer	2.09e-05	8.75e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—AMACR—prostate cancer	2.09e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP3A43—prostate cancer	2.09e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DEGS1—prostate cancer	2.09e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SRD5A2—prostate cancer	2.09e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAT1—prostate cancer	2.09e-05	0.00029	CbGpPWpGaD
Lisinopril—Dizziness—Epirubicin—prostate cancer	2.08e-05	8.71e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	2.07e-05	0.000286	CbGpPWpGaD
Lisinopril—Pruritus—Doxorubicin—prostate cancer	2.06e-05	8.62e-05	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	2.01e-05	0.000279	CbGpPWpGaD
Lisinopril—Vomiting—Epirubicin—prostate cancer	2e-05	8.38e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	2e-05	0.000277	CbGpPWpGaD
Lisinopril—Diarrhoea—Doxorubicin—prostate cancer	1.99e-05	8.34e-05	CcSEcCtD
Lisinopril—ABCB1—Metabolism—HSD17B1—prostate cancer	1.99e-05	0.000276	CbGpPWpGaD
Lisinopril—Rash—Epirubicin—prostate cancer	1.99e-05	8.31e-05	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—prostate cancer	1.98e-05	8.3e-05	CcSEcCtD
Lisinopril—Headache—Epirubicin—prostate cancer	1.97e-05	8.25e-05	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—prostate cancer	1.93e-05	8.06e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.9e-05	0.000263	CbGpPWpGaD
Lisinopril—Nausea—Epirubicin—prostate cancer	1.87e-05	7.82e-05	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—prostate cancer	1.85e-05	7.75e-05	CcSEcCtD
Lisinopril—Rash—Doxorubicin—prostate cancer	1.84e-05	7.69e-05	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—prostate cancer	1.84e-05	7.68e-05	CcSEcCtD
Lisinopril—Headache—Doxorubicin—prostate cancer	1.83e-05	7.64e-05	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.81e-05	0.000251	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.8e-05	0.00025	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.78e-05	0.000246	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—B4GALT4—prostate cancer	1.78e-05	0.000246	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HPGD—prostate cancer	1.78e-05	0.000246	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.75e-05	0.000243	CbGpPWpGaD
Lisinopril—Nausea—Doxorubicin—prostate cancer	1.73e-05	7.24e-05	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.71e-05	0.000238	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.71e-05	0.000237	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.67e-05	0.000231	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.63e-05	0.000226	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP7B1—prostate cancer	1.62e-05	0.000225	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTAP—prostate cancer	1.62e-05	0.000225	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.62e-05	0.000225	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.59e-05	0.000221	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SULT1E1—prostate cancer	1.58e-05	0.000219	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SRD5A1—prostate cancer	1.58e-05	0.000219	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.55e-05	0.000215	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.53e-05	0.000213	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACSL4—prostate cancer	1.51e-05	0.000209	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD17B3—prostate cancer	1.51e-05	0.000209	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.5e-05	0.000208	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.49e-05	0.000207	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ARG2—prostate cancer	1.45e-05	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PHGDH—prostate cancer	1.45e-05	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UMPS—prostate cancer	1.45e-05	0.000201	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.44e-05	0.0002	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.42e-05	0.000198	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LDHB—prostate cancer	1.42e-05	0.000197	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP3A5—prostate cancer	1.39e-05	0.000193	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.39e-05	0.000192	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.37e-05	0.00019	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.35e-05	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PDHA1—prostate cancer	1.35e-05	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA3—prostate cancer	1.35e-05	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UCP3—prostate cancer	1.35e-05	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TCN2—prostate cancer	1.35e-05	0.000187	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD3B1—prostate cancer	1.28e-05	0.000178	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC22A3—prostate cancer	1.28e-05	0.000178	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.24e-05	0.000172	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.24e-05	0.000172	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA4—prostate cancer	1.23e-05	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TBXAS1—prostate cancer	1.23e-05	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.21e-05	0.000168	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA2—prostate cancer	1.2e-05	0.000166	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SULT1A1—prostate cancer	1.18e-05	0.000164	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG5—prostate cancer	1.18e-05	0.000164	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA1—prostate cancer	1.16e-05	0.00016	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.15e-05	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAT2—prostate cancer	1.14e-05	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD3B2—prostate cancer	1.14e-05	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTO1—prostate cancer	1.14e-05	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLCB2—prostate cancer	1.1e-05	0.000152	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LRP2—prostate cancer	1.1e-05	0.000152	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2C18—prostate cancer	1.1e-05	0.000152	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—P4HB—prostate cancer	1.08e-05	0.000149	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.05e-05	0.000146	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC22A1—prostate cancer	1.05e-05	0.000145	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.05e-05	0.000145	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SULT2A1—prostate cancer	1.02e-05	0.000141	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.02e-05	0.000141	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MED12—prostate cancer	1e-05	0.000139	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNG5—prostate cancer	9.95e-06	0.000138	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA3—prostate cancer	9.59e-06	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HPGDS—prostate cancer	9.15e-06	0.000127	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2C19—prostate cancer	9.09e-06	0.000126	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTT1—prostate cancer	8.87e-06	0.000123	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACHE—prostate cancer	8.87e-06	0.000123	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2A6—prostate cancer	8.77e-06	0.000122	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	8.61e-06	0.000119	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C3—prostate cancer	8.53e-06	0.000118	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PRKACB—prostate cancer	8.49e-06	0.000118	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP17A1—prostate cancer	8.4e-06	0.000116	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.31e-06	0.000115	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA2—prostate cancer	8e-06	0.000111	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A5—prostate cancer	7.63e-06	0.000106	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2E1—prostate cancer	7.46e-06	0.000103	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NQO1—prostate cancer	7.37e-06	0.000102	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TH—prostate cancer	7.27e-06	0.000101	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP3A4—prostate cancer	7.19e-06	9.97e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1B1—prostate cancer	7.07e-06	9.8e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GGT1—prostate cancer	6.85e-06	9.49e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA1—prostate cancer	6.74e-06	9.35e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP19A1—prostate cancer	6.65e-06	9.22e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RXRA—prostate cancer	6.41e-06	8.89e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—COMT—prostate cancer	6.18e-06	8.57e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTP1—prostate cancer	6.15e-06	8.53e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ITPR1—prostate cancer	6.05e-06	8.39e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMS—prostate cancer	5.72e-06	7.93e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—prostate cancer	5.65e-06	7.84e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPL—prostate cancer	5.55e-06	7.69e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1A1—prostate cancer	5.36e-06	7.43e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ERCC2—prostate cancer	5.31e-06	7.37e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—prostate cancer	4.99e-06	6.93e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARA—prostate cancer	4.9e-06	6.79e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAV1—prostate cancer	4.61e-06	6.39e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—prostate cancer	4.2e-06	5.82e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INS—prostate cancer	3.97e-06	5.51e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CREBBP—prostate cancer	3.89e-06	5.39e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CD—prostate cancer	3.69e-06	5.12e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—prostate cancer	3.48e-06	4.83e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CB—prostate cancer	3.22e-06	4.46e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—prostate cancer	3.19e-06	4.42e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTEN—prostate cancer	2.78e-06	3.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—EP300—prostate cancer	2.65e-06	3.67e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—prostate cancer	1.96e-06	2.72e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—prostate cancer	1.6e-06	2.22e-05	CbGpPWpGaD
